Triphenylamines Displaying High Two-Photon Absorption
in DMF (2 mL) were added acid 30 (39.5 mg, 6.53 × 10-2 mmol,
1.0 equiv), EDCI (13.7 mg, 71.5 µmol, 1.1 equiv), and HOAt (11
mg, 80.8 µmol, 1.2 equiv). The mixture was stirred 7 days at rt in
the dark. The mixture was then diluted with CH2Cl2 (60 mL) and
washed with water (3 × 15 mL). The aqueous phase was extracted
with CH2Cl2 (10 mL). The organic phases were combined and dried
over Na2SO4. The product was dried under reduced pressure to
remove DMF and then purified by preparative TLC (SiO2 2 mm,
elution with CH2Cl2/MeOH 95/5) to give 31 as an orange solid
(16 mg, 30% yield).
chromatography (elution with a MeOH gradient 0 to 1% in CH2-
Cl2) to afford the product as an orange powder (275 mg, 530 µmol)
in 75% yield.
1
Mp 80 °C. H NMR (CDCl3) δ 1.23 (t, J ) 6.6 Hz, 3H), 2.12
(quint, J ) 6.6 Hz, 2H), 2.50 (t, J ) 6.6 Hz, 2H), 3.96 (t, J ) 6.6
Hz, 2H), 4.11 (q, 6.6 Hz, 2H), 6.69 (br, 1H), 6.73 (br, d, J ) 8.4
Hz, 1H), 7.25 (br, dd, J ) 8.7 Hz, 4H), 7.77 (d, J ) 8.1 Hz, 1H),
7.84 (d, J ) 8.7 Hz, 4H), 9.93 (s, 2H), 10.35 (s, 1H). 13C NMR
(CDCl3) δ 14.2, 24.2, 30.5, 60.6, 67.5, 108.1, 117.0, 121.7, 122.8,
124.6, 130.1, 131.4, 132.6, 151.1, 152.5, 162.3, 172.8, 187.9, 190.5.
HRMS (ESI+) calcd for C27H25NaNO6 482.1580, found 482.1563.
1H NMR (CDCl3) δ 1.44 (s, 9H), 3.22 (br s, 2H), 3.44 (t, J )
5.4 Hz, 4H), 3.49 (d, J ) 5.1 Hz, 2H), 3.68 (br s, 4H), 4.91 (br s,
1H, NH), 6.43 (br s, 1H, NH), 6.95 (d, J ) 16.2 Hz, 1H), 6.98 (d,
J ) 16.2 Hz, 2H), 7.17 (d, J ) 8.4 Hz, 4H), 7.22 (d, J ) 8.4 Hz,
1H), 7.27 (d, J ) 2.4 Hz, 1H), 7.31 (d, J ) 16.2 Hz, 2H), 7.41 (br
s, 6H), 7.51 (d, J ) 8.4 Hz, 4H), 7.67 (d, J ) 8.4 Hz, 1H), 7.70 (d,
J ) 16.2 Hz, 1H), 8.63 (br s, 6H). 13C NMR (CDCl3) δ 28.4, 39.9,
40.3, 69.7, 39.8, 70.1, 70.3, 79.5, 122.2, 124.7, 125.2, 127.1, 127.6,
128.3, 129.0, 129.9, 131.8, 132.3, 144.7, 146.9, 147.1, 150.1, 155.9.
MS (FAB+) m/z 829.5 (75%) [M + H]+, m/z 729.5 (18%) [M -
Boc + H]+, m/z 581.3 (88%) [M + H - (NH-((CH)2O)2 -(CH2)2-
NH2)]+. HRMS (DCI+) calcd for C51H53N6O 828.3999, found
829.4048.
4-[Bis(4-formylphenyl)amino]-2-hydroxybenzaldehyde (32).
To a suspension of AlCl3 (575 mg, 4.31 mmol, 5 equiv) in dry
CH2Cl2 (10 mL) at -10 °C was added a solution of 17 (310 mg,
860 µmol) in CH2Cl2 (5 mL) dropwise. The mixture was stirred at
reflux overnight then poured into an ice/water mixture and
vigorously stirred for 10 min. The mixture was extracted with CH2-
Cl2. The combined organic layers were washed with water and
brine, dried (Na2SO4), and concentrated to afford a crude solid that
was triturated in n-hexane to give 32 as a yellow powder (260 mg,
754 µmol) in 87% yield.
3-[8-(2,5-Dioxo-1-aza)cyclopent-3-enyl]octyloxy- 4-[(E)-2-
(benzothiazol-2-yl)vinyl]-N,N-(bis{4-[(E)-2-(benzothiazol-2-yl)]-
vinyl}phenyl)aniline (36). Compound 35 (24 mg, 25.8 µmol), rac-
7-oxabicyclo[2.2.1]heptene-2,3-dicarboxylic imide (5 mg, 28.4
µmol, 1.1 equiv), and K2CO3 (18 mg, 129 µmol, 5 equiv) were
dissolved in dry DMF (500 µL). The resulting suspension was
stirred at 55 °C overnight. The reaction course was monitored by
TLC. Once starting material disappearance was noticed, the crude
mixture was diluted in CH2Cl2 and washed with water. The
combined organic phases were dried and concentrated. The residue
was redissolved in anisole (5 mL) and refluxed 2 h. Anisole was
vacuum distilled and the residue was purified by preparative TLC
(CH2Cl2/MeOH, 400:3, v/v) repeatedly, until separation. The title
compound was isolated as an orange powder (11 mg, 12 µmol) in
47% yield.
Mp 80 °C. IR (KBr pellet) 1508 (Ar), 1590 (Ar), 1702 (νCdO
)
cm-1. 1H NMR (CDCl3) δ 1.30-1.60 (br, 10H), 1.85 (quint, 2H),
3.52 (t, J ) 7.2 Hz, 2H), 3.93 (t, J ) 6.3 Hz, 2H), 6.67 (s, 4H),
6.72 (d, J ) 1.8 Hz, 1H), 6.77 (dd, J ) 1.8 Hz, 8.4 Hz, 1H), 7.22
(d, J ) 8.4 Hz, 4H), 7.33-7.60 (m, 16 H), 7.84 (d, J ) 16.2 Hz,
1H), 7.90 (m, 3H), 8.01 (d, J ) 7.6 Hz, 1H), 8.03 (d, J ) 7.6 Hz,
2H). 13C NMR (CDCl3) δ 26.1, 26.6, 28.5, 29.0, 29.1, 29.2, 37.9,
68.6, 108.0, 116.9, 120.4, 121.0, 121.4, 121.5, 122.7, 122.9, 124.4,
125.0, 125.2, 126.3, 126.4, 128.7, 128.9, 130.6, 132.7, 134.0, 134.4
(2C), 136.8, 147.6, 148.9, 153.9, 154.0, 158.1, 167.3, 168.6, 171.0.
HRMS (FAB+) calcd for C57H47N5O3S3 946.2919, found 946.2884.
Mp 242-244 °C. 1H NMR (CDCl3) δ 6.64 (d, J ) 1.8 Hz, 1H),
6.71 (dd, J ) 1.8, 8.4 Hz, 1H), 7.30 (d, J ) 8.4 Hz, 4H), 7.49 (d,
J ) 8.4 Hz, 1H), 7.88 (d, J ) 8.4 Hz, 4H), 9.78 (s, 1H), 9.97 (s,
2H), 11.33 (s, 1H). 13C NMR (CDCl3) δ 110.9, 115.0, 117.1, 125.4,
131.5, 133.1, 135.1, 150.8, 153.3, 163.4, 190.5, 194.3. HRMS
(DCI+) calcd for C21H16NO4 346.1079, found 346.1088.
2-(8-Bromooctyloxy)-4-[N,N-bis(4-formylphenyl)]aminoben-
zaldehyde (33). Compound 32 (100 mg, 290 µmol), 1,8-dibro-
mooctane (800 µL, 1.18 g, 4.34 mmol, 15 equiv), and K2CO3 (100
mg, 723 µmol, 2.5 equiv) were dissolved in dry acetone (10 mL).
The white suspension was stirred at 45 °C for 24 h. Diethyl ether
was added and the mixture filtered through a Celite pad. After
concentration, the residue was purified by column chromatography
(CH2Cl2/n-hexane 1:1 to 4:1 then CH2Cl2 and CH2Cl2/MeOH 99.5:
0.5). The title compound was isolated as a yellow solid (130 mg,
242 µmol) in 84% yield.
4-{5-[Bis(4-[(E)-2-(1,3-benzothiazol-2-yl)vinyl]phenyl)amino]-
2-[(E)-2-(1,3-benzothiazol-2-yl)vinyl]phenoxy}butanoic Acid (38).
A mixture of ester 37 (60 mg, 0.070 mmol) in THF (2 mL) and a
saturated aqueous LiOH solution (2 mL) was stirred overnight at
rt. The reaction was acidified to pH 2 and extracted with CH2Cl2.
The combined organic layers were washed with water and brine,
dried (Na2SO4), and concentrated to afford a crude oil. Purification
by silica gel column chromatography (CH2Cl2/MeOH, 98:2, v/v)
afforded the product as an orange powder (52 mg, 63 µmol) in
90% yield.
1
Mp 146-149 °C. H NMR (CDCl3) δ 2.32 (br, 2H), 2.59 (br,
2H), 4.01 (t, J ) 6.0 Hz, 2H), 6.67 (d, J ) 1.8 Hz, 1H), 6.75 (dd,
J ) 1.8 Hz, 8.4 Hz, 1H), 7.21 (d, J ) 8.4 Hz, 4H), 7.30-7.65 (m,
16H), 7.86-7.91 (m, 3H), 8.01-8.04 (m, 3H), 8.14 (d, J ) 15.0
Hz, 1H). 13C NMR (CDCl3) δ 25.0, 32.0, 68.6, 107.5, 116.9, 119.4,
120.1, 121.0, 121.5, 122.2, 122.8, 124.6, 125.0, 125.2, 126.5, 128.5,
128.7, 130.9, 132.8, 134.1, 134.3, 137.0, 147.5, 149.0, 153.1, 153.9,
158.1, 167.2, 168.7. HRMS (FAB+) calcd for C49H36N4O3S3
825.1980, found 825.2030.
Mp 80 °C. IR (KBr pellet) 2852 (νC-H, formyl), 2738 (νC-H
,
formyl), 1696 (νCdO), 1588 (Ar), 1505 (Ar) cm-1. 1H NMR (CDCl3)
δ 1.30-1.55 (br, 8H), 1.79 (quint, J ) 6.6 Hz, 2H), 1.88 (quint, J
) 6.6 Hz, 2H), 3.43 (t, J ) 6.6 Hz, 2H), 3.91 (t, J ) 6.6 Hz, 2H),
6.68 (d, J ) 1.8 Hz, 1H), 6.74 (dd, J ) 1.8, 8.4 Hz, 1H), 7.28 (d,
J ) 8.4 Hz, 4H), 7.82 (d, J ) 8.4 Hz, 1H), 7.87 (d, J ) 8.4 Hz,
4H), 9.98 (s, 2H), 10.42 (s, 1H). 13C NMR (CDCl3) δ 25.9, 28.0,
28.6, 28.9, 29.1, 32.7, 33.9, 68.7, 108.2, 116.9, 121.7, 124.5, 130.0,
131.4, 132.6, 151.2, 152.5, 162.7, 188.1, 190.5. HRMS (DCI+)
calcd for C29H3179BrNO4 536.1436, found 536.1437. HRMS (DCI+)
calcd for C29H3181BrNO4 538.1421, found 538.1434.
Succinimidyl 4-{5-[Bis(4-[(E)-2-(1,3-benzothiazol-2-yl)vinyl]-
phenyl)amino]-2-[(E)-2-(1,3-benzothiazol-2-yl)vinyl]phenoxy}-
butanoate (39). A solution of compound 38 (40 mg, 48.5 µmol, 1
equiv), N-hydroxysuccinimide (9 mg, 78 µmol, 1.6 equiv), and DCC
(11 mg, 56 µmol, 1.1 equiv) in dry CH2Cl2 was stirred for 24 h.
The cloudy suspension was filtered, concentrated, and redissolved
in CH2Cl2. The procedure was repeated five times to afford the
title compound as a yellow powder (25 mg, 27 µmol) in 66% yield.
Ethyl 4-{5-[Bis(4-formylphenyl)amino]-2-formylphenoxy}-
butanoate (34). To a solution of 32 (280 mg, 810 µmol) in dry
DMF (12 mL) was added K2CO3 (1.1 g, 8.0 mmol, 10 equiv). The
reaction was stirred for 15 min and ethyl bromobutanoate (175 µL,
1.22 mmol, 1.5 equiv) was added slowly. The mixture was stirred
24 h at rt and concentrated. The residue was redissolved in CH2-
Cl2 and water and extracted with CH2Cl2. The combined organic
layers were washed with water and brine, dried (Na2SO4), and
concentrated to afford a crude solid purified by silica gel column
1
Mp 80 °C. H NMR (CDCl3) δ 2.34 (quint, J ) 6.3 Hz, 2H),
2.83 (s, 4H), 2.93 (t, J ) 6.3 Hz, 2H), 4.06 (t, J ) 6.0 Hz, 2H),
6.73 (d, J ) 1.8 Hz, 1H), 6.80 (dd, J ) 1.8 Hz, 8.4 Hz, 1H), 7.22
(d, J ) 8.4 Hz, 4H), 7.35-7.65 (m, 16H), 7.83 (d, J ) 16.5 Hz,
J. Org. Chem, Vol. 73, No. 5, 2008 1743